Multifunctional indanone–chalcone hybrid compounds with anti-β-amyloid (Aβ) aggregation, monoamine oxidase B (MAO-B) inhibition and neuroprotective properties against Alzheimer’s disease
暂无分享,去创建一个
Wenmin Liu | Jian Shi | Lintao Yu | Zhipei Sang | Keren Wang
[1] Hua Zhang,et al. Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation , 2019, Molecules.
[2] Wenmin Liu,et al. Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease. , 2018, ACS chemical neuroscience.
[3] S. Sensi,et al. Copper and Zinc Dysregulation in Alzheimer's Disease. , 2018, Trends in pharmacological sciences.
[4] Kris Simone Tranches Dias,et al. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update. , 2018, Current medicinal chemistry.
[5] D. Lamba,et al. Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues. , 2018 .
[6] Nasimul Hoda,et al. Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules. , 2018, Current topics in medicinal chemistry.
[7] D. Lamba,et al. Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues , 2018, Journal of enzyme inhibition and medicinal chemistry.
[8] J. Hardy,et al. Alzheimer's disease , 2018, European journal of neurology.
[9] S. Patil,et al. Recent developments in biological activities of indanones. , 2017, European journal of medicinal chemistry.
[10] J. Andersen,et al. Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[11] Ernesto Fedele,et al. The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind , 2017, Current neuropharmacology.
[12] C. Xing,et al. Chalcone: A Privileged Structure in Medicinal Chemistry. , 2017, Chemical reviews.
[13] Yan Li,et al. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties. , 2017, Bioorganic & medicinal chemistry.
[14] B. Kumar,et al. A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities. , 2016, Current drug targets.
[15] Yan Li,et al. Synthesis and evaluation of 4-hydroxyl aurone derivatives as multifunctional agents for the treatment of Alzheimer's disease. , 2016, Bioorganic & medicinal chemistry.
[16] D. Desiderio,et al. Design, Synthesis, and Evaluation of Donepezil-Like Compounds as AChE and BACE-1 Inhibitors. , 2016, ACS medicinal chemistry letters.
[17] T. H. Ferreira-Vieira,et al. Alzheimer's Disease: Targeting the Cholinergic System , 2016, Current neuropharmacology.
[18] Youfu Luo,et al. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease. , 2015, European journal of medicinal chemistry.
[19] S. Vilar,et al. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study. , 2013, European journal of medicinal chemistry.
[20] Xingshu Li,et al. Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease. , 2012, Journal of medicinal chemistry.
[21] Maurizio Recanatini,et al. Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.
[22] Li Di,et al. High throughput artificial membrane permeability assay for blood-brain barrier. , 2003, European journal of medicinal chemistry.